Gut microbiome modulates efficacy of immune checkpoint inhibitors

Immune checkpoint inhibitors (ICIs) therapy is a novel strategy for cancer treatments in recent years. However, it was observed that most patients treated with ICIs could not get benefit from the therapy, which led to the limitation of clinical application. Motivated by potent and durable efficacy o...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Hematol Oncol
Huvudupphovsmän: Yi, Ming, Yu, Shengnan, Qin, Shuang, Liu, Qian, Xu, Hanxiao, Zhao, Weiheng, Chu, Qian, Wu, Kongming
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2018
Ämnen:
Review
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5870075/
https://ncbi.nlm.nih.gov/pubmed/29580257
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-018-0592-6
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk